Psychedelic Companies Researching End-of-Life Distress

Psilocybin-assisted therapy has shown profound effects on existential distress, anxiety, and depression in patients facing terminal illness. Landmark studies at NYU, Johns Hopkins, and other institutions have driven significant interest.